Neonatal diabetes, a hereditary disease causing high blood sugar in newborns, requires comprehensive care from various ...

The collaboration between NABH and RSSDI seeks to elevate diabetes care quality by establishing robust accreditation ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

WHAM continues its coverage of National Diabetes Month with a look at some tools to manage it and foods to consider adding to ...

The National Accreditation Board for Hospitals and Healthcare Providers (NABH), a constituent body of  Quality Council of India (QCI), on Tuesday inked a pact with the Research Society for the Study ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

There could be a simple way to lower your blood sugar levels and reduce your risk of heart disease - and it involves adding a ...

Diabetes does not discriminate with age.Though adults aged 45–64 receive the majority of new diabetes diagnoses in the U.S., ...

Prioritising eye health through timely check-ups and proactive management is crucial for individuals with diabetes to ...

Discover the truth behind Sugar Defender with real customer insights and detailed Sugar Defender reviews – is it for you?

Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records: Our Bureau, Mumbai Tuesday, November 19, 2024, 15:30 Hrs [IST] Emcure Pharmaceuticals, a l ...

Dr. Michael Jurua, the head of the private wing at Arua Regional Referral Hospital, emphasized that regular screening makes ...